Onset of efficacy of LY2951742 in migraine prevention: Data from a phase IIa, randomized, double-blind, placebo-controlled study of a monoclonal antibody to calcitonin gene-related peptide (a post-hoc analysis)

Authors
Category Primary study
ConferencePostgraduate Medicine
Year 2016
This article has no abstract
Epistemonikos ID: 773de83ec57e9a174db347fd137defb5448ea5c7
First added on: Apr 29, 2026